References
- Acion, L., Kelmansky, D., Van Der Laan, M., Sahker, E., Jones, D., Arndt, S., & Niaura, R. (2017). Use of a machine learning framework to predict substance use disorder treatment success. PLoS One, 12(4), e0175383. doi:https://doi.org/10.1371/journal.pone.0175383
- Ahrnsbrak, R., Bose, J., Hedden, S. L., & Lipari, R. N. (2017). Key substance use and mental health indicators in the United States: Results from the 2016 national survey on drug use and health. Retrieved from https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR1-2016/NSDUH-FFR1-%0A2016.htm#sud7
- Brown, E. N., Purdon, P. L., & Van Dort, C. J. (2011). General anesthesia and altered states of arousal: A systems neuroscience analysis. Annual Review of Neuroscience, 34(1), 601–628. doi:https://doi.org/10.1146/annurev-neuro-060909-153200
- Carlezon, W. A., & Thomas, M. J. (2009). Biological substrates of reward and aversion: A nucleus accumbens activity hypothesis. Neuropharmacology, 56, 122–132. doi:https://doi.org/10.1016/j.neuropharm.2008.06.075
- Centers for Disease Control and Prevention. (2017). Wide-ranging online data for epidemiologic research (WONDER). Retrieved from https://wonder.cdc.gov/
- Centers for Disease Control and Prevention. (2018). Fact sheets - Alcohol use and health – Alcohol. Retrieved from https://www.cdc.gov/alcohol/fact-sheets/alcohol-use.htm
- Chavkin, C., & Koob, G.F. (2016). Dynorphin, dysphoria, and dependence: The stress of addiction. Neuropsyhopharmacology, 41(1), 373–374. doi:https://doi.org/10.1038/npp.2015.258
- Connery, H. S. (2015). Medication-assisted treatment of opioid use disorder. Harvard Review of Psychiatry, 23(2), 63–75. doi:https://doi.org/10.1097/hrp.0000000000000075
- Conway, C., George, M. S., & Sackeim, H. S. (2017). Toward an evidence-based, operational definition of treatment-resistant depression: When enough is enough. JAMA Psychiatry, 74(1), 9–10. doi:https://doi.org/10.1001/jamapsychiatry.2016.2586
- Crist, R. C., Li, J., Doyle, G. A., Gilbert, A., Dechairo, B. M., & Berrettini, W. H. (2018). Pharmacogenetic analysis of opioid dependence treatment dose and dropout rate. The American Journal of Drug and Alcohol Abuse, 44(4), 431–440. doi:https://doi.org/10.1080/00952990.2017.1420795
- Darcq, E., & Kieffer, B. L. (2018). Opioid receptors: Drivers to addiction? Nature Reviews Neuroscience, 19(8), 499–514. doi:https://doi.org/10.1038/s41583-018-0028-x
- DiClemente, C. C., Bellino, L. E., & Neavins, T. M. (1999). Motivation for change and alcoholism treatment. Alcohol Research & Health, 23(2), 86–92.
- Dyck, M. J. (1994). Treatment-resistant depression: A critique of current approaches. Australasian Psychiatry, 28(1), 34–41. doi:https://doi.org/10.3109/00048679409075843
- Elman, I. (2016). Common brain mechanisms of chronic pain and addiction. Elsevier, 89, 11–36. Retrieved from https://www.sciencedirect.com/science/article/pii/S0896627315010338
- Gold, M. S., Pottash, A. L., Extein, I., & Kleber, H. (1980, November). Anti-endorphin effects of methadone. The Lancet, 316(8201), 972–973. doi:https://doi.org/10.1016/S0140-6736(80)92125-X
- Hedegaard, H., Warner, M., & Miniño, A. (2018). Drug overdose deaths in the United States, 1999-2017. Retrieved from https://pdfs.semanticscholar.org/d9fb/9f85f17b86409fb1980955ff4e9a51eb086e.pdf
- Klimas, J., Gorfinkel, L., Giacomuzzi, S. M., Ruckes, C., Socías, M. E., Fairbairn, N., & Wood, E. (2019). Slow release oral morphine versus methadone for the treatment of opioid use disorder. BMJ Open, 9(4), 25799. doi:https://doi.org/10.1136/bmjopen-2018-025799
- Koob, G. F. (2006). The neurobiology of addiction: A neuroadaptational view relevant for diagnosis. Addiction, 101, 23–30. doi:https://doi.org/10.1111/j.1360-0443.2006.01586.x
- Koob, G. F., & Le Moal, M. (2008). Addiction and the brain antireward system. Annual Review of Psychology, 59(1), 29–53. doi:https://doi.org/10.1146/annurev.psych.59.103006.093548
- Leshner, A. (1997). Addiction is a brain disease and it matters. Science, 5335(278), 45–47. doi: https://doi.org/10.1126/science.278.5335.45
- Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews, (3). doi:https://doi.org/10.1002/14651858.CD002209.pub2
- McIntyre, R. S., Filteau, M.-J., Martin, L., Patry, S., Carvalho, A., Cha, D. S., … Miguelez, M. (2014). Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach. Journal of Affective Disorders, 156, 1–7. doi:https://doi.org/10.1016/j.jad.2013.10.043
- Meredith, G. E., Baldo, B. A., Andrezjewski, M. E., & Kelley, A. E. (2008). The structural basis for mapping behavior onto the ventral striatum and its subdivisions. Brain Structure and Function, 213(1–2), 17–27. doi:https://doi.org/10.1007/s00429-008-0175-3
- Miller, W. R., & Rollnick, S. (1991). Motivational interviewing: Preparing people to change addictive behavior. New York, NY: Guilford Press.
- National Academies of Science. (2019). Medications for opioid use disorder save lives. Medications for opioid use disorder save lives. National Academies Press. doi:https://doi.org/10.17226/25310
- Patterson Silver Wolf, D. A., & Gold, M. (2020). Treatment resistant opioid use disorder (TROUD): Definition, rationale, and recommendations. Journal of the Neurological Sciences, 411, 116718. doi:https://doi.org/10.1016/j.jns.2020.116718
- Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2018). Drug and opioid-involved overdose deaths - United States, 2013-2017. MMWR. Morbidity and Mortality Weekly Report, 67(5152), 1419–1427. doi:https://doi.org/10.15585/mmwr.mm675152e1
- Valentino, R. J., & Volkow, N. V. (2018). Untangling the complexity of opioid receptor function. Neuropsychopharmacology, 43, 2514–2520. Retrieved from https://www.nature.com/articles/s41386-018-0225-3/
- Volkow, N. D., & Collins, F. S. (2017). The role of science in addressing the opioid crisis. New England Journal of Medicine, 377(4), 391–394. doi:https://doi.org/10.1056/NEJMsr1706626
- Volkow, N. D., Koob, G. F., & McLellan, T. A. (2016). Neurobiologic advances from the brain disease model of addiction. The New England Journal of Medicine, 374(4), 363–371. doi:https://doi.org/10.1056/nejmra1511480